Mary M. Sugrue

Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)

Axel Grothey, Mary M. Sugrue, David M. Purdie et al. · Journal of Clinical Oncology · 2008 · 692 citations · Full text

Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study

Mark Kozloff, Marianne Ulcickas Yood, Jordan Berlin et al. · The Oncologist · 2009 · 307 citations · Full text

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53

Mary M. Sugrue, Deug Y. Shin, Sam W. Lee et al. · Proceedings of the National Academy of Sciences · 1997 · 291 citations · Full text

Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.

Siavash K. Kurdistani, P. Arizti, Corinne Reimer et al. · PubMed · 1998 · 266 citations

Tumor Cell Growth, Dna Damage, Cell Death +16

p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53

Fang Li, Makoto Igarashi, Jennifer Leung et al. · Oncogene · 1999 · 200 citations

Tumor Biology, Functional P53, Replicative Senescence +9